$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Medical News
Medical News
ALK lung cancer drug Alectinib’s medical insurance reimbursement ratio in 2021
2025-10-19 11:44:20
Check Details
Contraindications and precautions for patients with lung cancer taking Xalkori
2025-10-19 11:44:20
Check Details
Iressa is the first-line treatment option for non-small cell lung cancer
2025-10-19 11:44:20
Check Details
What are the indications for which the immune drug nivolumab is approved by the FDA?
2025-10-19 11:44:20
Check Details
Anshengsa has good results in treating ALK-positive lung cancer
2025-10-19 11:44:20
Check Details
How much does the targeted lung cancer treatment drug Iressa cost per month?
2025-10-19 11:44:20
Check Details
How long can patients with lung cancer take Iressa?
2025-10-19 11:44:20
Check Details
Dacomitinib has good results in the treatment of metastatic non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Where can I buy the lung cancer immune drug nivolumab? How much does it cost?
2025-10-19 11:44:20
Check Details
First-line treatment for metastatic non-small cell lung cancer: gefitinib
2025-10-19 11:44:20
Check Details
ALK-positive targeted drug for lung cancer: Alectinib
2025-10-19 11:44:20
Check Details
Has the immunotherapy drug nivolumab been approved for marketing in China?
2025-10-19 11:44:20
Check Details
1
2
...
9924
9925
9926
9927
9928
9929
9930
...
10204
10205
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
What diseases can Upatinib be used for? Which patients are suitable for use?
2
The efficacy of Eltrombopag
3
User Agreement
4
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
5
What is the most important information I should know about WELIREG?
6
How to take and store WELIREG
7
How to take TRUSELTIQ correctly
8
How to deal with LONSURF side effects (1)
9
How to deal with LONSURF side effects (2)
10
Cabozantinib (Cabometyx)-new indication approved
11
What should I pay attention to when using atezolizumab/Tecentriq?
12
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma